Dacomitinib is an oral pill that blocks a protein called EGFR. It’s used for advanced lung cancer where certain gene mutations are present. These mutations are found in folks who’ve already taken other EGFR or ALK inhibitors and their cancer has advanced.
This drug blocks signals from a certain protein, EGFR, which helps keep cancer in check. It comes in three strengths: 15 mg, 30 mg, and 45 mg tablets. The doctor usually recommends taking a 45 mg tablet in the morning, on an empty stomach, whether you’ve eaten before or not.
It comes in bottles of 30 tablets apiece. You got to keep ’em cool—stored at around room temperature, around 25 degrees Centigrade. Folks with liver problems might need a dose tweak.
This drug is a kinase inhibitor that’s all about helping with NSCLC, especially EGFR-mutated kind.
